Standard pre‑examination protocol – must be demonstrated:
Action: Introduce yourself, explain the examination, and obtain verbal consent.
Key observations:
Systematic motor & sensory exam:
Systematic examination:
Assess:
📋 Case Presentation – (fill in during exam)
This is a _____-year-old _____ child, referred for _____ (stiff legs / difficulty walking / frequent falls). On examination, the child appears _____ (well/unwell), with _____ (scissoring gait / toe‑walking). Neurological exam: tone in lower limbs _____ (increased/spastic), power _____ (reduced), reflexes _____ (brisk), clonus _____ (present/absent), plantars _____ (extensor). Upper limbs: tone _____ (normal / increased), power _____, reflexes _____. Sensation: _____ (normal / impaired). Eye findings: fundi _____ (normal / optic atrophy). Growth: weight _____ percentile, height _____ percentile. Associated signs: _____ (pes cavus, scoliosis, urinary urgency).
• Hereditary Spastic Paraplegia (HSP) – pure or complicated.
• Cerebral Palsy (spastic diplegia) – perinatal insult, static.
• Spinal cord compression – tumour, trauma, infection (TB).
• Adrenoleukodystrophy – progressive, adrenal insufficiency.
• Friedreich ataxia – ataxia, sensory loss, cardiomyopathy.
• Vitamin B12 deficiency – subacute combined degeneration.
• HTLV-1 associated myelopathy (HAM) – tropical spastic paraparesis.
• Syringomyelia – sensory dissociation, segmental muscle wasting.
• Multiple sclerosis – relapsing‑remitting, optic neuritis.
• Dopa‑responsive dystonia – diurnal variation, responds to L‑dopa.
• Primary lateral sclerosis – upper motor neuron only.
• Functional – non‑organic.
• Brain MRI – periventricular leukomalacia (CP), atrophy (HSP).
• Spinal MRI – cord compression, atrophy, syrinx.
• Genetic testing – SPG genes (SPG4, SPG3A, SPG11, etc.).
• NCS/EMG – to exclude peripheral neuropathy.
• Genetic testing – targeted panel for HSP genes.
• MRI brain – thin corpus callosum (SPG11), white matter changes.
• VLCFA – adrenoleukodystrophy.
• Vitamin B12, folate – nutritional.
• HTLV-1 serology – if travel/endemic area.
• CSF – if infection/demyelination suspected.
• MRI spine – cord compression, syrinx.
• CSF – oligoclonal bands (MS), infection.
• Evoked potentials – VEPs (optic neuritis).
• Metabolic screen – amino acids, organic acids.
• Copper/caeruloplasmin – Wilson disease (if mixed).
• Urodynamics – neurogenic bladder.
• Orthopaedics – scoliosis, hip dislocation.
• Ophthalmology – optic atrophy (complicated HSP).
• Audiology – hearing impairment (complicated).
• Physiotherapy – functional assessment.
🔹 Management – Across Organ Systems
Spasticity: physiotherapy, stretching, botulinum toxin, baclofen (oral/IT), tizanidine.
Contractures: tendon releases, osteotomies; scoliosis: bracing, surgery; pes cavus: orthotics.
Neurogenic bladder: anticholinergics (oxybutynin), intermittent catheterisation, urology referral.
Physiotherapy, OT, gait aids (ankle‑foot orthoses, walking sticks).
Recurrence risk (AD, AR, X‑linked), carrier testing, prenatal diagnosis.
Muscle spasms: benzodiazepines, baclofen, gabapentin.
Vitamin B12 replacement (if deficient), folate.
Support groups, counselling, school support.
📈 Prognosis
📋 Follow‑up Schedule